Report Detail
Global (United States, European Union and China) Famciclovir Market Research Report 2019-2025
- RnM3648076 |
- 06 August, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Famciclovir is an antiviral drug. It slows the growth and spread of the herpes virus so that the body can fight off the infection. Famciclovir will not cure herpes, but it can lessen the symptoms of the infections.
In 2019, the market size of Famciclovir is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Famciclovir.
This report studies the global market size of Famciclovir, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Famciclovir sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Novartis
Mylan
Teva
Cipla
Hikma
Apotex
Aurobindo Pharma
Macleods Pharmaceuticals
Beijing Jialin Pharmaceutical
HETERO
Hainan choitec Pharmaceuticals
Shandong Luoxin Pharmaceutical Group
Chengdu Diao Pharmaceutical Group
HISUN
Market Segment by Product Type
125 mg Tablets
250 mg Tablets
500 mg Tablets
Market Segment by Application
Cold sores
Genital herpes
Shingles
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Famciclovir status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Famciclovir manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Famciclovir are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Famciclovir Market Size Growth Rate by Type (2019-2025)
- 1.3.2 125 mg Tablets
- 1.3.3 250 mg Tablets
- 1.3.4 500 mg Tablets
- 1.4 Market Segment by Application
- 1.4.1 Global Famciclovir Market Share by Application (2019-2025)
- 1.4.2 Cold sores
- 1.4.3 Genital herpes
- 1.4.4 Shingles
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Famciclovir Market Size
- 2.1.1 Global Famciclovir Revenue 2014-2025
- 2.1.2 Global Famciclovir Sales 2014-2025
- 2.2 Famciclovir Growth Rate by Regions
- 2.2.1 Global Famciclovir Sales by Regions 2014-2019
- 2.2.2 Global Famciclovir Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Famciclovir Sales by Manufacturers
- 3.1.1 Famciclovir Sales by Manufacturers 2014-2019
- 3.1.2 Famciclovir Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Famciclovir Revenue by Manufacturers (2014-2019)
- 3.2.2 Famciclovir Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Famciclovir Market Concentration Ratio (CR5 and HHI)
- 3.3 Famciclovir Price by Manufacturers
- 3.4 Key Manufacturers Famciclovir Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Famciclovir Market
- 3.6 Key Manufacturers Famciclovir Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 125 mg Tablets Sales and Revenue (2014-2019)
- 4.1.2 250 mg Tablets Sales and Revenue (2014-2019)
- 4.1.3 500 mg Tablets Sales and Revenue (2014-2019)
- 4.2 Global Famciclovir Sales Market Share by Type
- 4.3 Global Famciclovir Revenue Market Share by Type
- 4.4 Famciclovir Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Famciclovir Sales by Application
6 United States
- 6.1 United States Famciclovir Breakdown Data by Company
- 6.2 United States Famciclovir Breakdown Data by Type
- 6.3 United States Famciclovir Breakdown Data by Application
7 European Union
- 7.1 European Union Famciclovir Breakdown Data by Company
- 7.2 European Union Famciclovir Breakdown Data by Type
- 7.3 European Union Famciclovir Breakdown Data by Application
8 China
- 8.1 China Famciclovir Breakdown Data by Company
- 8.2 China Famciclovir Breakdown Data by Type
- 8.3 China Famciclovir Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Famciclovir Breakdown Data by Company
- 9.2 Rest of World Famciclovir Breakdown Data by Type
- 9.3 Rest of World Famciclovir Breakdown Data by Application
- 9.4 Rest of World Famciclovir Breakdown Data by Countries
- 9.4.1 Rest of World Famciclovir Sales by Countries
- 9.4.2 Rest of World Famciclovir Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Novartis
- 10.1.1 Novartis Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Famciclovir
- 10.1.4 Famciclovir Product Introduction
- 10.1.5 Novartis Recent Development
- 10.2 Mylan
- 10.2.1 Mylan Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Famciclovir
- 10.2.4 Famciclovir Product Introduction
- 10.2.5 Mylan Recent Development
- 10.3 Teva
- 10.3.1 Teva Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Famciclovir
- 10.3.4 Famciclovir Product Introduction
- 10.3.5 Teva Recent Development
- 10.4 Cipla
- 10.4.1 Cipla Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Famciclovir
- 10.4.4 Famciclovir Product Introduction
- 10.4.5 Cipla Recent Development
- 10.5 Hikma
- 10.5.1 Hikma Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Famciclovir
- 10.5.4 Famciclovir Product Introduction
- 10.5.5 Hikma Recent Development
- 10.6 Apotex
- 10.6.1 Apotex Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Famciclovir
- 10.6.4 Famciclovir Product Introduction
- 10.6.5 Apotex Recent Development
- 10.7 Aurobindo Pharma
- 10.7.1 Aurobindo Pharma Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Famciclovir
- 10.7.4 Famciclovir Product Introduction
- 10.7.5 Aurobindo Pharma Recent Development
- 10.8 Macleods Pharmaceuticals
- 10.8.1 Macleods Pharmaceuticals Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Famciclovir
- 10.8.4 Famciclovir Product Introduction
- 10.8.5 Macleods Pharmaceuticals Recent Development
- 10.9 Beijing Jialin Pharmaceutical
- 10.9.1 Beijing Jialin Pharmaceutical Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Famciclovir
- 10.9.4 Famciclovir Product Introduction
- 10.9.5 Beijing Jialin Pharmaceutical Recent Development
- 10.10 HETERO
- 10.10.1 HETERO Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Famciclovir
- 10.10.4 Famciclovir Product Introduction
- 10.10.5 HETERO Recent Development
- 10.11 Hainan choitec Pharmaceuticals
- 10.12 Shandong Luoxin Pharmaceutical Group
- 10.13 Chengdu Diao Pharmaceutical Group
- 10.14 HISUN
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Famciclovir Sales Channels
- 11.2.2 Famciclovir Distributors
- 11.3 Famciclovir Customers
12 Market Forecast
- 12.1 Global Famciclovir Sales and Revenue Forecast 2019-2025
- 12.2 Global Famciclovir Sales Forecast by Type
- 12.3 Global Famciclovir Sales Forecast by Application
- 12.4 Famciclovir Forecast by Regions
- 12.4.1 Global Famciclovir Sales Forecast by Regions 2019-2025
- 12.4.2 Global Famciclovir Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Famciclovir. Industry analysis & Market Report on Famciclovir is a syndicated market report, published as Global (United States, European Union and China) Famciclovir Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Famciclovir market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
